Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million. The Seprafilm product family, which is used as an adjunct to reduce the incidence, extent and severity of adhesions in certain pelvic and abdominal surgeries, currently has a global commercial presence in the U.S., Japan, China, South Korea and France, among other countries.
Read the full article: Baxter Completes Acquisition of Seprafilm Adhesion Barrier //
Source: https://www.businesswire.com/news/home/20200218005291/en/Baxter-Completes-Acquisition-Seprafilm-Adhesion-Barrier